IP insight

Half Your Patents Are Liabilities: The IP Portfolio Pruning Playbook That Saves Six Figures a Year

Hayat Amin · Updated 2026-10-30

IP portfolio pruning is the discipline most patent-holding companies skip — and it costs them six figures a year in maintenance fees on patents that generate zero revenue and zero defensive value.

Half your patent portfolio is costing you money every year with nothing to show for it. IP portfolio pruning — the disciplined annual review that kills underperforming patents and doubles down on the winners — is the single highest-ROI exercise a patent-holding company can run. Most never do it.

According to Ocean Tomo's 2025 Intangible Asset Market Value Study, intangible assets now account for 90% of S&P 500 market capitalisation. Yet a 2024 Dennemeyer study found that 40–60% of patents in a typical corporate portfolio generate no licensing revenue and provide no measurable defensive value. Hayat Amin argues this gap is not a filing problem — it is a management problem. "Companies file patents because their attorneys tell them to. Nobody asks whether the patent earns its keep three years later," Amin says. The fix is not to file less. It is to prune harder.

What Is IP Portfolio Pruning?

IP portfolio pruning is the systematic process of evaluating every patent in a portfolio against revenue potential, defensive coverage, and maintenance cost — then abandoning the assets that fail all three tests. It is the IP equivalent of cutting underperforming products from a product line. Companies that prune annually save an average of $50,000 to $500,000 per year in maintenance fees alone, depending on portfolio size.

Most companies treat their patent portfolio as a filing cabinet — they add to it but never subtract. This creates a compounding cost problem. Patent maintenance fees escalate over time: a US utility patent costs $1,600 at the 3.5-year mark, $3,600 at 7.5 years, and $7,400 at 11.5 years (USPTO 2025 fee schedule, large entity). Multiply that across 50 or 100 patents and the annual maintenance bill quietly exceeds six figures while nobody questions whether each patent still earns its place.

Pruning is not reckless. It is strategic. The goal is to redirect resources — both fees and management attention — toward the patents that drive revenue, block competitors, or support licensing programmes. Every dollar saved on a dead patent can be reinvested into filing stronger claims or funding an enforcement campaign on a patent that actually matters.

How Much Do Unused Patents Actually Cost?

A mid-size technology company with 80 patents pays between $120,000 and $300,000 per year in maintenance fees, annuities, and administrative costs — for a portfolio where fewer than half the assets generate any commercial return. The real cost is higher when you include the legal hours spent on prior art monitoring, freedom-to-operate analysis, and prosecution for patents that will never be asserted or licensed.

Hayat Amin's framework at Beyond Elevation breaks patent cost into three layers: direct fees (maintenance and annuities), indirect management cost (attorney time, docket administration, renewal tracking), and opportunity cost (the enforcement or licensing action you could fund with the savings). "Most CFOs see the direct fees on a line item. Nobody calculates what the portfolio could earn if you redirected that budget into monetising the top 20 patents instead of maintaining all 80," Amin says.

For international portfolios the numbers get sharper. European patent validation and renewal fees across five jurisdictions can exceed $15,000 per patent per year. A company maintaining 30 European patents it does not actively use or licence is spending $450,000 annually on dead weight. That is a Series A round's worth of runway burned every three years on patents that block nothing and earn nothing.

Which Patents Should You Kill?

The patents you should abandon are the ones that score zero on all three of these tests: they generate no licensing revenue, they block no identifiable competitor, and they cover technology the company has moved past. Hayat Amin's Patent Kill Test asks four questions to surface these liabilities fast.

Question 1: Does this patent map to current or planned products? If the patent covers technology the company no longer uses and has no plan to use in the next 24 months, it is a candidate for abandonment. Technology evolves. Products pivot. Patents filed in year one often cover architectures that year-three products replaced entirely.

Question 2: Does any competitor practise this claim? If no competitor infringes — and none is likely to in the patent's remaining life — the patent has zero enforcement value. A patent that nobody needs to work around is a patent nobody will pay to license. Check litigation analytics platforms for competitor activity in the patent's claim space before deciding.

Question 3: Could this patent generate licensing revenue in its remaining life? A patent with six years of remaining term covering an active technology standard is worth keeping. A patent with three years left covering an abandoned protocol is not. Map each patent's remaining term against the market lifecycle of the technology it covers.

Question 4: What does it cost to maintain for the remainder of the term? Calculate the total remaining maintenance cost — not just the next renewal. A patent costing $22,000 over its remaining seven years that scores zero on the first three questions is a clear kill. Redirect those $22,000 into a continuation filing on your strongest active family.

How Often Should You Review Your Patent Portfolio?

Effective IP portfolio pruning happens on an annual cadence, timed to coincide with budget planning and at least 90 days before the next wave of renewal deadlines. This gives the team enough lead time to make abandonment decisions without paying the next fee while debating. Beyond Elevation runs quarterly portfolio reviews for clients with more than 100 patents, but the minimum cadence for any portfolio holder is once per year.

The review should not be run by patent attorneys alone. Hayat Amin reminds founders that attorneys are paid to file and renew — asking them which patents to kill is like asking a real estate agent which properties to sell at a loss. The review needs a commercial operator who can evaluate each patent against the company's current business model, competitive landscape, and licensing pipeline. This is exactly the function a fractional Chief IP Officer fills.

A structured review follows a simple process: export the full patent docket, map each patent to a business unit or product line, score each patent on the four-question kill test, and present the bottom quartile to leadership with a recommendation to abandon or maintain with justification. The entire exercise takes two to three days for a 100-patent portfolio when led by someone who knows both the technology and the market.

What Happens When You Prune Successfully?

Companies that prune aggressively see three outcomes. First, immediate cost savings — typically 20% to 40% of annual maintenance spend in the first year. Second, sharper licensing programmes, because the remaining portfolio is concentrated on the patents that matter, making enforcement and licensing negotiations faster and more credible. Third, better investor optics: a lean, high-quality portfolio signals operational discipline in due diligence.

Hayat Amin proved this principle when restructuring a portfolio into a focused licensing engine that now generates eight figures in recurring royalties. The restructuring started with a prune: identifying which patents had real market coverage, which overlapped without adding defensive depth, and which covered technology the market had moved past. The patents that survived the cut became the foundation of a licensing programme. The ones that did not were abandoned, saving six figures in annual maintenance that was redirected into enforcement on the remaining high-value assets.

The inverse is equally instructive. Companies that never prune accumulate what Amin calls "portfolio drag" — the annual cost of maintaining assets that dilute the average quality of the portfolio, slow down freedom-to-operate searches, and confuse licensing targets about which patents actually matter. Portfolio drag compounds every year a dead patent is renewed.

Who Should Run Your Portfolio Review?

A fractional Chief IP Officer is purpose-built for this function. Unlike outside patent counsel — who bills hourly and has a structural incentive to maintain and renew — a CIPO operates on the company's side of the table, aligned with commercial outcomes. Hayat Amin's approach at Beyond Elevation pairs the IP review with a financial model: what does each patent cost to hold, what could it earn, and what is the net present value of keeping versus killing. The decision becomes a spreadsheet, not a legal opinion.

If your patent portfolio has more than 20 assets and you have not reviewed it in the last 12 months, you are almost certainly overpaying. Book an IP portfolio review with Beyond Elevation and find out which patents are earning their keep — and which ones should have been killed years ago.

FAQ

How much can IP portfolio pruning save per year?

For a mid-size technology company with 50 to 100 patents, pruning typically saves $50,000 to $300,000 per year in maintenance fees alone. International portfolios with European and Asian coverage often save more because per-patent renewal costs are higher across multiple jurisdictions.

Will abandoning a patent help competitors?

Only if the patent covers technology a competitor actively practises. If no competitor infringes the patent's claims — which is the case for the majority of abandoned patents — letting it lapse has zero competitive impact. The patents you kill are the ones nobody needs.

Can you reverse a patent abandonment?

In most jurisdictions, including the US and Europe, there is a limited window to petition for revival after a missed maintenance payment — typically six months to two years, with additional fees. Strategic pruning is an intentional decision, not an oversight. If the kill test says abandon, you should not need to reverse it.

Should startups with small portfolios bother pruning?

Yes. Even a portfolio of five patents should be reviewed annually. A startup paying maintenance on a patent that no longer aligns with its product roadmap is wasting money that could fund a new filing on technology that matters. Pruning discipline starts early.

How does pruning affect patent portfolio valuation?

A pruned portfolio is typically valued higher per patent because the average quality increases. Acquirers and investors prefer a focused portfolio of 30 high-quality patents over a bloated portfolio of 80 mixed-quality assets. Pruning raises the floor and sharpens the licensing story.